Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceu...

Global small molecule contract development and manufacturing organization (CDMO) market will reach $117,920.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, th...

2023-01-03 | Healthcare and Social Assistance

Asia Pacific Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restle...

Asia Pacific Sleep Aids market will grow by 8.5% annually with a total addressable market cap of $325,998.9 billion over 2022-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep ...

12/31/2022 | Healthcare and Social Assistance

Europe Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg...

Europe Sleep Aids market was valued at $ 22,840.5 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a num...

12/31/2022 | Healthcare and Social Assistance

North America Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restl...

North America Sleep Aids market is projected to grow by 5.5% annually in the forecast period and reach $53,183.0 million by 2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep ai...

12/31/2022 | Healthcare and Social Assistance

Global Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg...

Global Sleep Aids market will reach $159,756.6 million by 2031, growing by 6.7% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of g...

2023-01-03 | Healthcare and Social Assistance

Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, En...

Asia Pacific Rapid Diagnostics will grow by 10.9% annually with a total addressable market cap of $ 129,373.7 million over 2022-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for ra...

12/31/2022 | Healthcare and Social Assistance

Europe Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User...

Europe Rapid Diagnostics was valued at $ 9,950.1 million in 2021 and will grow by 5.6% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in...

12/31/2022 | Healthcare and Social Assistance

North America Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, E...

North America Rapid Diagnostics is projected to grow by 6.5% annually in the forecast period and reach $29,905.4 million by 2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid ...

12/31/2022 | Healthcare and Social Assistance

Global Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User...

Global Rapid Diagnostics market will reach $ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in...

2023-01-03 | Healthcare and Social Assistance

2022-2027 Global and Regional Adjustable Dental Articulators Industry Status and Prospects Professional Market Research Report Standard Version

The global Adjustable Dental Articulators market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

9/26/2022 | Pharma & Healthcare

Global small molecule contract development and manufacturing organization (CDMO) market will reach $117,920.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures. Highlighted with 83 tables and 84 figures, this 166-page report “Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceutical Firms, Biotechnology Firms), Therapeutic Area (Infectious Diseases, Oncology, Ophthalmology, Cardiovascular Disorders, Central Nervous System, Respiratory Disorders, Metabolic Diseases), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global small molecule contract development and manufacturing organization (CDMO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global small molecule contract development and manufacturing organization (CDMO) market in every aspect of the classification from perspectives of Product Type, Service Type, Customer Type, Therapeutic Area, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Active Pharmaceutical Ingredients (API) o Branded Drugs o Generic Drugs • Finished Dosage Formulations (FDF) o Oral Solid Drugs o Injectable Drugs o Semi-solid or Liquid Drugs o Other FDFs Based on Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Preclinical Use • Clinical Use o Phase I o Phase II o Phase III o Phase IV • Commercial Use By Customer Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical Firms • Biotechnology Firms By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Infectious Diseases • Oncology • Ophthalmology • Cardiovascular Disorders • Central Nervous System • Respiratory Disorders • Metabolic Diseases • Other Therapeutic Areas Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Service Type and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Boehringer Ingelheim Cambrex Corporation Catalent Cipla Covance Inc. Lonza Group Ltd. Medley Pharmaceuticals NatcoPharma Patheon (Thermo Fisher Scientific, Inc.) Piramal Pharma Solutions RedHillBiopharma Siegfried Holding AG STA Pharmaceutical Sun Pharmaceutical Teva (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

2023-01-03

Asia Pacific Sleep Aids market will grow by 8.5% annually with a total addressable market cap of $325,998.9 billion over 2022-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices. Highlighted with 29 tables and 51 figures, this 117-page report “Asia Pacific Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Smart Bedding • Sleep Lab Services • Sleep Apnea Devices o Adaptive Servo-Ventilators (ASVs) o Positive Airway Pressure (PAP) Devices o Oral Appliances o Facial Interfaces o Other Sleep Apnea Devices • Medication o Prescription Drugs o OTC Drugs o Herbal Drugs • Wearable Devices • Other Product Types Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Insomnia • Sleep Apnea • Narcolepsy • Restless Leg Syndrome • REM Sleep Behavior Disorder • Sleepwalking • Other Indications By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Stores • E-Commerce • Hospital Pharmacies • Retail Pharmacies Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Advanced Brain Monitoring Inc. Apex Medical Corp. Apnea Sciences Corporation BMC Medical Co., Ltd. Braebon Medical Corp. Cadwell Industries Inc. Cleveland Medical Devices Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. Fisher & Paykel Healthcare Corp. Ltd. GlaxoSmithKline plc Itamer Medical Ltd. Koninklijke Philips N. V. Merck & Co., Inc. Natus Medical Inc. Nihon Kohden Corporation Pfizer Inc. ResMed Inc. Sanofi S. A. Sleep Number Corporation SleepMed Inc. SomnoMed Inc. Teva Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

12/31/2022

Europe Sleep Aids market was valued at $ 22,840.5 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices. Highlighted with 32 tables and 52 figures, this 117-page report “Europe Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Smart Bedding • Sleep Lab Services • Sleep Apnea Devices o Adaptive Servo-Ventilators (ASVs) o Positive Airway Pressure (PAP) Devices o Oral Appliances o Facial Interfaces o Other Sleep Apnea Devices • Medication o Prescription Drugs o OTC Drugs o Herbal Drugs • Wearable Devices • Other Product Types Based on Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Insomnia • Sleep Apnea • Narcolepsy • Restless Leg Syndrome • REM Sleep Behavior Disorder • Sleepwalking • Other Indications By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Stores • E-Commerce • Hospital Pharmacies • Retail Pharmacies Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Advanced Brain Monitoring Inc. Apex Medical Corp. Apnea Sciences Corporation BMC Medical Co., Ltd. Braebon Medical Corp. Cadwell Industries Inc. Cleveland Medical Devices Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. Fisher & Paykel Healthcare Corp. Ltd. GlaxoSmithKline plc Itamer Medical Ltd. Koninklijke Philips N. V. Merck & Co., Inc. Natus Medical Inc. Nihon Kohden Corporation Pfizer Inc. ResMed Inc. Sanofi S. A. Sleep Number Corporation SleepMed Inc. SomnoMed Inc. Teva Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

12/31/2022

North America Sleep Aids market is projected to grow by 5.5% annually in the forecast period and reach $53,183.0 million by 2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices. Highlighted with 22 tables and 48 figures, this 109-page report “North America Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Smart Bedding • Sleep Lab Services • Sleep Apnea Devices o Adaptive Servo-Ventilators (ASVs) o Positive Airway Pressure (PAP) Devices o Oral Appliances o Facial Interfaces o Other Sleep Apnea Devices • Medication o Prescription Drugs o OTC Drugs o Herbal Drugs • Wearable Devices • Other Product Types Based on Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Insomnia • Sleep Apnea • Narcolepsy • Restless Leg Syndrome • REM Sleep Behavior Disorder • Sleepwalking • Other Indications By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Stores • E-Commerce • Hospital Pharmacies • Retail Pharmacies Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Advanced Brain Monitoring Inc. Apex Medical Corp. Apnea Sciences Corporation BMC Medical Co., Ltd. Braebon Medical Corp. Cadwell Industries Inc. Cleveland Medical Devices Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. Fisher & Paykel Healthcare Corp. Ltd. GlaxoSmithKline plc Itamer Medical Ltd. Koninklijke Philips N. V. Merck & Co., Inc. Natus Medical Inc. Nihon Kohden Corporation Pfizer Inc. ResMed Inc. Sanofi S. A. Sleep Number Corporation SleepMed Inc. SomnoMed Inc. Teva Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

12/31/2022

Global Sleep Aids market will reach $159,756.6 million by 2031, growing by 6.7% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices. Highlighted with 81 tables and 84 figures, this 170-page report “Global Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Smart Bedding • Sleep Lab Services • Sleep Apnea Devices o Adaptive Servo-Ventilators (ASVs) o Positive Airway Pressure (PAP) Devices o Oral Appliances o Facial Interfaces o Other Sleep Apnea Devices • Medication o Prescription Drugs o OTC Drugs o Herbal Drugs • Wearable Devices • Other Product Types Based on Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Insomnia • Sleep Apnea • Narcolepsy • Restless Leg Syndrome • REM Sleep Behavior Disorder • Sleepwalking • Other Indications By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Stores • E-Commerce • Hospital Pharmacies • Retail Pharmacies Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Indication and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Advanced Brain Monitoring Inc. Apex Medical Corp. Apnea Sciences Corporation BMC Medical Co., Ltd. Braebon Medical Corp. Cadwell Industries Inc. Cleveland Medical Devices Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. Fisher & Paykel Healthcare Corp. Ltd. GlaxoSmithKline plc Itamer Medical Ltd. Koninklijke Philips N. V. Merck & Co., Inc. Natus Medical Inc. Nihon Kohden Corporation Pfizer Inc. ResMed Inc. Sanofi S. A. Sleep Number Corporation SleepMed Inc. SomnoMed Inc. Teva Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

2023-01-03

Asia Pacific Rapid Diagnostics will grow by 10.9% annually with a total addressable market cap of $ 129,373.7 million over 2022-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. Highlighted with 35 tables and 64 figures, this 126-page report “Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables • Analyzers/Instruments Based on Prescription, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Professional Diagnostics • OTC Based Testing By Platform, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Immunoassays o Lateral Flow Assays o Serological Assays o Other Immunoassays • Molecular Detection o Polymerase Chain Reaction (PCR) o Other Molecular Detection Tests • Other Platforms By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood Glucose Testing • Cardiometabolic Testing • Infectious Disease Testing o COVID-19 Testing o Healthcare-associated Infections (HAI) Testing o Hepatitis Testing o Tropical Diseases Testing o HIV Testing o Influenza Testing o Sexually Transmitted Diseases (STD) Testing o Other Infectious Diseases Testing • Blood Coagulation Testing • Hematology Testing • Cancer Testing • Drug Abuse Testing • Pregnancy & Fertility Testing • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals & Clinics • Laboratories • Individuals/Homecare • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Prescription and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Diagnostics ACON Laboratories Becton Dickinson and Co. BioMérieux S.A. Bio-Rad Laboratories, Inc. Chembio Diagnostic Systems Danaher Corp. F. Hoffmann La Roche Ltd. GlySens Inc. Meridian Bioscience Inc. OraSure Technologies Inc. Siemens Healthineers AG Thermo Fisher Scientific Inc. Trinity Biotech Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

12/31/2022

Europe Rapid Diagnostics was valued at $ 9,950.1 million in 2021 and will grow by 5.6% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. Highlighted with 38 tables and 65 figures, this 127-page report “Europe Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables • Analyzers/Instruments Based on Prescription, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Professional Diagnostics • OTC Based Testing By Platform, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Immunoassays o Lateral Flow Assays o Serological Assays o Other Immunoassays • Molecular Detection o Polymerase Chain Reaction (PCR) o Other Molecular Detection Tests • Other Platforms By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood Glucose Testing • Cardiometabolic Testing • Infectious Disease Testing o COVID-19 Testing o Healthcare-associated Infections (HAI) Testing o Hepatitis Testing o Tropical Diseases Testing o HIV Testing o Influenza Testing o Sexually Transmitted Diseases (STD) Testing o Other Infectious Diseases Testing • Blood Coagulation Testing • Hematology Testing • Cancer Testing • Drug Abuse Testing • Pregnancy & Fertility Testing • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals & Clinics • Laboratories • Individuals/Homecare • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Prescription and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Diagnostics ACON Laboratories Becton Dickinson and Co. BioMérieux S.A. Bio-Rad Laboratories, Inc. Chembio Diagnostic Systems Danaher Corp. F. Hoffmann La Roche Ltd. GlySens Inc. Meridian Bioscience Inc. OraSure Technologies Inc. Siemens Healthineers AG Thermo Fisher Scientific Inc. Trinity Biotech Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

12/31/2022

North America Rapid Diagnostics is projected to grow by 6.5% annually in the forecast period and reach $29,905.4 million by 2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. Highlighted with 28 tables and 61 figures, this 120-page report “North America Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Country. Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables • Analyzers/Instruments Based on Prescription, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Professional Diagnostics • OTC Based Testing By Platform, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Immunoassays o Lateral Flow Assays o Serological Assays o Other Immunoassays • Molecular Detection o Polymerase Chain Reaction (PCR) o Other Molecular Detection Tests • Other Platforms By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood Glucose Testing • Cardiometabolic Testing • Infectious Disease Testing o COVID-19 Testing o Healthcare-associated Infections (HAI) Testing o Hepatitis Testing o Tropical Diseases Testing o HIV Testing o Influenza Testing o Sexually Transmitted Diseases (STD) Testing o Other Infectious Diseases Testing • Blood Coagulation Testing • Hematology Testing • Cancer Testing • Drug Abuse Testing • Pregnancy & Fertility Testing • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals & Clinics • Laboratories • Individuals/Homecare • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Prescription and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Diagnostics ACON Laboratories Becton Dickinson and Co. BioMérieux S.A. Bio-Rad Laboratories, Inc. Chembio Diagnostic Systems Danaher Corp. F. Hoffmann La Roche Ltd. GlySens Inc. Meridian Bioscience Inc. OraSure Technologies Inc. Siemens Healthineers AG Thermo Fisher Scientific Inc. Trinity Biotech Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

12/31/2022

Global Rapid Diagnostics market will reach $ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. Highlighted with 83 tables and 97 figures, this 183-page report “Global Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables • Analyzers/Instruments Based on Prescription, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Professional Diagnostics • OTC Based Testing By Platform, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Immunoassays o Lateral Flow Assays o Serological Assays o Other Immunoassays • Molecular Detection o Polymerase Chain Reaction (PCR) o Other Molecular Detection Tests • Other Platforms By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood Glucose Testing • Cardiometabolic Testing • Infectious Disease Testing o COVID-19 Testing o Healthcare-associated Infections (HAI) Testing o Hepatitis Testing o Tropical Diseases Testing o HIV Testing o Influenza Testing o Sexually Transmitted Diseases (STD) Testing o Other Infectious Diseases Testing • Blood Coagulation Testing • Hematology Testing • Cancer Testing • Drug Abuse Testing • Pregnancy & Fertility Testing • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals & Clinics • Laboratories • Individuals/Homecare • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Prescription and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Diagnostics ACON Laboratories Becton Dickinson and Co. BioMérieux S.A. Bio-Rad Laboratories, Inc. Chembio Diagnostic Systems Danaher Corp. F. Hoffmann La Roche Ltd. GlySens Inc. Meridian Bioscience Inc. OraSure Technologies Inc. Siemens Healthineers AG Thermo Fisher Scientific Inc. Trinity Biotech Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

2023-01-03

The global Adjustable Dental Articulators market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: SAM-Dental Home Whip Mix Shofu Amann Girrbach Keystone Industries Dentatus Lingchen Dental SMEDENT Nissin Dental KaVo. Dental By Types: Ordinary Metal Dental Articulators Ceramic Dental Articulators By Applications: Hospitals Dental Clnics Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and Drivers: Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements. ...

9/26/2022

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT